Inactivation of endothelial ZEB1 impedes tumor progression and sensitizes tumors to conventional therapies

Journal: Journal of Clinical Investigation

Published: 2020-03-02

DOI: 10.1172/jci131507

Affiliations: 7

Authors: 12

Go to article
Institutions Share
State Key Laboratory of Natural Medicines (SKLNM), CPU, China 0.42
China Pharmaceutical University (CPU), China 0.42
Michigan Medicine, U-M, United States of America (USA) 0.08
University of Glasgow, United Kingdom (UK) 0.08

Return